NASDAQ:NAOV NanoVibronix (NAOV) Stock Price, News & Analysis $0.73 +0.01 (+1.39%) (As of 12:08 PM ET) Add Compare Share Share Today's Range$0.71▼$0.7350-Day Range$0.69▼$0.8652-Week Range$0.67▼$4.23Volume2,178 shsAverage Volume68,460 shsMarket Capitalization$2.03 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Get NanoVibronix alerts: Email Address Ad Crypto Swap ProfitsGrab Your Free Bitcoin Today!And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here About NanoVibronix Stock (NASDAQ:NAOV)NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. The company also offers PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing by using ultrasound to increase local capillary perfusion and tissue oxygenation. It sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, Australia, India, and internationally. The company was incorporated in 2003 and is headquartered in Elmsford, New York.Read More NAOV Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NAOV Stock News HeadlinesMay 22, 2024 | businesswire.comNanoVibronix Announces Commencement of UroShield Clinical Study at the University of MichiganMay 16, 2024 | businesswire.comNanoVibronix Issues Letter to StockholdersJuly 8, 2024 | Insiders Exposed (Ad)How did they achieve a perfect track record? If you want to learn how A Group of traders Made 917 Trades Without A Single Loss! And How You Could Have Consistently Beat the Market by following them...May 16, 2024 | investorplace.comNAOV Stock Earnings: NanoVibronix Reported Results for Q1 2024May 14, 2024 | finance.yahoo.comNanoVibronix Announces Distribution Agreement with VA Supplier CB Medical for the Distribution of UroShieldMay 1, 2024 | businesswire.comNanoVibronix Announces PainShield Will Be Included in Department of Veteran Affairs' FSS Contract AwardApril 10, 2024 | investorplace.comNAOV Stock Earnings: NanoVibronix Reported Results for Q4 2023April 9, 2024 | businesswire.comNanoVibronix Issues Letter to StockholdersJuly 8, 2024 | True Market Insiders (Ad)Exposed: 3 CENT Crypto to Explode June 24th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... Today, he is now making the biggest crypto call of his ENTIRE career…March 28, 2024 | finance.yahoo.comNanoVibronix Signs Agreement for Research and Development of Next Generation PainShield and UroShieldFebruary 23, 2024 | benzinga.comMagnolia Oil & Gas Stock (NYSE:MGY), Quotes and News SummaryFebruary 2, 2024 | uk.finance.yahoo.comNanoVibronix, Inc. (NAOV)January 7, 2024 | morningstar.comNanoVibronix Inc NAOVDecember 6, 2023 | finance.yahoo.comNanoVibronix Featured in Your Bladder Health MagazineDecember 4, 2023 | finance.yahoo.comNanoVibronix Enters into Letter of Intent with APOGEPHA Arzneimittel GmbH to Explore European Distribution OpportunityNovember 28, 2023 | markets.businessinsider.comNanoVibronix Stock Slips 10%, Sings Research Agreement With Regents Of The University Of MichiganNovember 28, 2023 | finance.yahoo.comNanoVibronix Announces Agreement for Clinical Study of UroShield at the University of MichiganNovember 7, 2023 | finance.yahoo.comNanoVibronix UroShield Products Available on NHS Drug Tariff Effective November 1See More Headlines Receive NAOV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NanoVibronix and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/15/2024Today7/08/2024Next Earnings (Estimated)8/09/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical appliances & supplies Sub-IndustryN/A Current SymbolNASDAQ:NAOV CUSIPN/A CIK1326706 Webwww.nanovibronix.com Phone(914) 233-3004Fax914-376-6111Employees10Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($1.69) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-3,710,000.00 Net Margins-112.35% Pretax Margin-111.16% Return on Equity-95.96% Return on Assets-53.14% Debt Debt-to-Equity RatioN/A Current Ratio2.45 Quick Ratio1.38 Sales & Book Value Annual Sales$2.28 million Price / Sales0.89 Cash FlowN/A Price / Cash FlowN/A Book Value$1.95 per share Price / Book0.37Miscellaneous Outstanding Shares2,780,000Free Float2,684,000Market Cap$2.03 million OptionableNot Optionable Beta1.54 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesMr. Brian M. Murphy (Age 67)CEO & Director Comp: $342.5kMr. Stephen R. Brown CPA (Age 68)Chief Financial Officer Comp: $276.5kDr. Harold Jacob M.D. (Age 70)Chief Medical Officer & Director Mr. Amir RippelVice President of MarketingMs. Lindsey HarrisonVice President of SalesKey CompetitorsPredictive OncologyNASDAQ:POAIHeart Test LaboratoriesNASDAQ:HSCSLogicMarkNASDAQ:LGMKBone BiologicsNASDAQ:BBLGSientraNASDAQ:SIENQView All Competitors NAOV Stock Analysis - Frequently Asked Questions How have NAOV shares performed this year? NanoVibronix's stock was trading at $1.15 at the start of the year. Since then, NAOV stock has decreased by 37.4% and is now trading at $0.72. View the best growth stocks for 2024 here. How were NanoVibronix's earnings last quarter? NanoVibronix, Inc. (NASDAQ:NAOV) released its quarterly earnings results on Wednesday, May, 15th. The company reported ($0.23) EPS for the quarter. The company had revenue of $0.92 million for the quarter. NanoVibronix had a negative net margin of 112.35% and a negative trailing twelve-month return on equity of 95.96%. When did NanoVibronix's stock split? NanoVibronix shares split on Thursday, October 13th 2022. The 2-1 split was announced on Thursday, October 13th 2022. The newly issued shares were payable to shareholders after the closing bell on Thursday, October 13th 2022. An investor that had 100 shares of stock prior to the split would have 200 shares after the split. How do I buy shares of NanoVibronix? Shares of NAOV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of NanoVibronix own? Based on aggregate information from My MarketBeat watchlists, some other companies that NanoVibronix investors own include T2 Biosystems (TTOO), ADMA Biologics (ADMA), Co-Diagnostics (CODX), Inovio Pharmaceuticals (INO), Tonix Pharmaceuticals (TNXP) and BIO-key International (BKYI). This page (NASDAQ:NAOV) was last updated on 7/8/2024 by MarketBeat.com Staff From Our PartnersNYSE biotech company's drug could be as revolutionary as penicillin!NV-387 could be a single drug to treat all of the "tripledemic" viruses and more! See how NV-387 could be h...Financial Markets Daily | SponsoredObama wins Presidential debate When I said Obama would seek a third term… They called me a conspiracy theorist, they said it couldn’t happ...Porter & Company | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored50-year Wall Street Legend: “Prepare for a cash avalanche”The Dow crossed 40,000 for the first time in history… The S&P has hit over 30 all-time highs since the star...Chaikin Analytics | SponsoredBiden to drop out; finish out his term?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in...Paradigm Press | SponsoredGrab Your Free Bitcoin Today!And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a v...Crypto Swap Profits | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredBiden Nomination CANCELED?And I believe when they do take the oath of office, their fingers will be crossed… and America will descend in...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NanoVibronix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NanoVibronix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
